Published in Br J Psychiatry on March 01, 1991
'The disease concept of alcoholism'. Br J Psychiatry (1991) 0.75
The alcohol dependence syndrome: a concept as stimulus to enquiry. Br J Addict (1986) 5.32
London's skid row. Lancet (1966) 5.09
Alcohol dependence: provisional description of a clinical syndrome. Br Med J (1976) 4.96
Science and the drinks industry: cause for concern. Addiction (1996) 4.63
Sensible drinking. BMJ (1996) 4.38
Alcoholism: a controlled trial of "treatment" and "advice". J Stud Alcohol (1977) 4.14
ILSI Europe, the drinks industry, and a conflict of interest undeclared. Addiction (2001) 3.76
A controlled trial of inpatient and outpatient treatment of alcohol dependency. Lancet (1967) 3.41
Specialist versus general practitioner treatment of problem drinkers. Lancet (1990) 2.88
Deaths of drug addicts in the United Kingdom 1967-81. Br Med J (Clin Res Ed) (1985) 2.35
Contemporary themes: relevance of american experience of narcotic addiction to the british scene. Br Med J (1967) 2.29
Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J Abnorm Child Psychol (2001) 2.27
The British approach to the treatment of heroin addiction. Lancet (1969) 2.26
Drugs, drug dependence and the concept of plasticity. Q J Stud Alcohol (1974) 2.17
The development of a questionnaire to measure severity of alcohol dependence. Br J Addict Alcohol Other Drugs (1979) 2.16
Abuse of methylamphetamine. Br Med J (1969) 2.15
Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA(LGA251). Clin Microbiol Infect (2012) 2.08
An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol (2004) 2.05
Addiction treatment and the making of large claims. Addiction (2000) 2.05
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet (1986) 2.04
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol (2001) 2.03
Shakespeare and the meaning of authorship. Addiction (2000) 2.02
Pharmacokinetics of halofantrine in man: effects of food and dose size. Br J Clin Pharmacol (1989) 1.97
Cocaine and crack. BMJ (1989) 1.96
Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol (2002) 1.94
Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br J Clin Pharmacol (1984) 1.82
Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol (2004) 1.67
Relevance and utility of courses in medical ethics. A survey of physicians' perceptions. JAMA (1985) 1.67
Census of a reception centre. Br J Psychiatry (1968) 1.64
Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol (1993) 1.64
Orthodontic auxiliaries--a pilot project. Br Dent J (1998) 1.59
Transcription factor E2F binds DNA as a heterodimer. Proc Natl Acad Sci U S A (1993) 1.53
Characterization of potassium currents modulated by BRL 38227 in rat portal vein. Br J Pharmacol (1992) 1.50
Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro Surveill (2003) 1.50
The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol (1987) 1.49
Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum. Bull World Health Organ (1981) 1.46
The alcoholic doctor. A case of neglect. Lancet (1975) 1.45
Hypnosis and desinsitization for Phobias: a controlled prospective trial. Br J Psychiatry (1968) 1.40
Abstinence or control: the outcome for excessive drinkers two years after consultation. Behav Res Ther (1976) 1.40
Effects of methyl beta-cyclodextrin on EDHF responses in pig and rat arteries; association between SK(Ca) channels and caveolin-rich domains. Br J Pharmacol (2007) 1.39
A paper which must be withdrawn from publication. Addiction (2001) 1.38
The disposition of amodiaquine in Zambians and Nigerians with malaria. Br J Clin Pharmacol (1990) 1.34
Determination of primaquine in biological fluids by reversed-phase high-performance liquid chromatography. J Chromatogr (1984) 1.30
Drinking problems: putting the Third World on the map. Lancet (1979) 1.30
Cardiovascular toxicity and distribution kinetics of intravenous chloroquine. Br J Clin Pharmacol (1986) 1.30
Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol (2004) 1.29
Differences between the effects of cromakalim and nifedipine on agonist-induced responses in rabbit aorta. Br J Pharmacol (1991) 1.29
Monitoring changing patterns of drug dependence in accident and emergency departments. Drug Alcohol Depend (1987) 1.29
Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. Br J Clin Pharmacol (1985) 1.27
The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br J Pharmacol (1990) 1.26
A role in migration for the alpha V beta 1 integrin expressed on oligodendrocyte precursors. J Neurosci (1996) 1.25
The efficacy of problem-solving communication training alone, behavior management training alone, and their combination for parent-adolescent conflict in teenagers with ADHD and ODD. J Consult Clin Psychol (2001) 1.25
Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery. Br J Pharmacol (1997) 1.24
The drunk in court: survey of drunkenness offenders from two London courts. Br Med J (1968) 1.23
Alcoholics admitted to four hospitals in England. II. General and cause-specific mortality. Q J Stud Alcohol (1974) 1.23
Posthysterectomy vault prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2000) 1.22
The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism. Br J Clin Pharmacol (1990) 1.21
The Addiction Research Unit of the Institute of Psychiatry, University of London--I. The work of the unit's drug and alcohol section, and general issues. Br J Addict (1989) 1.21
Studies on the effects of anandamide in rat hepatic artery. Br J Pharmacol (1997) 1.19
Impairment of endothelial SK(Ca) channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats. Br J Pharmacol (2010) 1.19
The safety and kinetics of intramuscular quinine in Malawian children with moderately severe falciparum malaria. Trans R Soc Trop Med Hyg (1991) 1.18
Alcoholics admitted to four hospitals in England. I. Social class and the interaction of alcoholics with the treatment system. Q J Stud Alcohol (1974) 1.18
Suppression of K(+)-induced hyperpolarization by phenylephrine in rat mesenteric artery: relevance to studies of endothelium-derived hyperpolarizing factor. Br J Pharmacol (2001) 1.17
High-performance liquid chromatographic analysis of amodiaquine in human plasma. J Chromatogr (1985) 1.17
Measurement of bladder volume following cesarean section using bladderscan. Int Urogynecol J Pelvic Floor Dysfunct (2001) 1.16
Patients with drinking problems. Br Med J (1968) 1.14
Potassium channel modulation in rat portal vein by ATP depletion: a comparison with the effects of levcromakalim (BRL 38227). Br J Pharmacol (1992) 1.14
Bupivacaine and Kaltostat reduces post-operative donor site pain. Br J Plast Surg (1993) 1.12
A 1-year prospective study of burns in an Irish paediatric burns unit. Burns (1996) 1.12
The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus. Ann Trop Med Parasitol (2003) 1.11
What happens to alcoholics? Lancet (1983) 1.10
Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine. Clin Chem (1992) 1.10
Effects of P1060 and aprikalim on whole-cell currents in rat portal vein; inhibition by glibenclamide and phentolamine. Br J Pharmacol (1993) 1.10
Clients of alcoholism information centres. Br Med J (1967) 1.10
Division of labor of Schwann cell integrins during migration on peripheral nerve extracellular matrix ligands. Dev Biol (1997) 1.09
Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes. Br J Pharmacol (1998) 1.09
Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions. Br J Clin Pharmacol (2002) 1.08
Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br J Pharmacol (1996) 1.08
A cluster of Legionnaires' disease caused by Legionella longbeachae linked to potting compost in Scotland, 2008-2009. Euro Surveill (2010) 1.07
Setting up a therapeutic community. Lancet (1966) 1.07
British policies on opiate addiction: ten years working of the revised response, and options for the future. Br J Psychiatry (1979) 1.06
Determination of halofantrine and its principal metabolite desbutylhalofantrine in biological fluids by reversed-phase high-performance liquid chromatography. J Chromatogr (1988) 1.06
Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects. Br J Clin Pharmacol (1985) 1.05
Selective determination, in plasma, of artemether and its major metabolite, dihydroartemisinin, by high-performance liquid chromatography with ultraviolet detection. J Chromatogr (1992) 1.04
K+-induced hyperpolarization in rat mesenteric artery: identification, localization and role of Na+/K+-ATPases. Br J Pharmacol (2002) 1.04
Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria. Br J Clin Pharmacol (1991) 1.04
A comparison of drug-related problems in London Accident and Emergency Departments 1975-1982. Br J Psychiatry (1986) 1.03
Simultaneous determination of artemether and its major metabolite dihydroartemisinin in plasma by gas chromatography-mass spectrometry-selected ion monitoring. J Chromatogr B Biomed Sci Appl (1999) 1.02
Treatment with coumarin to prevent or delay recurrence of malignant melanoma. J Cancer Res Clin Oncol (1994) 1.02
Role of endothelial cell hyperpolarization in EDHF-mediated responses in the guinea-pig carotid artery. Br J Pharmacol (2000) 1.02
The involvement of potassium channels in the action of ciclazindol in rat portal vein. Br J Pharmacol (1992) 1.01
Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria. Br J Clin Pharmacol (1994) 1.00
Advanced technology in the management of fibrous dysplasia. J Plast Reconstr Aesthet Surg (2008) 1.00
Alcoholics known or unknown to agencies: epidemiological studies in a London suburb. Br J Psychiatry (1973) 0.99
Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br J Clin Pharmacol (2000) 0.99
The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. Ann Trop Med Parasitol (2004) 0.99
The effect of oxygen on CO2 fixation by mesophyll protoplast extracts of C3 and C4 plants. Biochem Biophys Res Commun (1975) 0.99
The expression and function of Ca(2+)-sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes. Br J Pharmacol (2008) 0.98
Analytical Debye-Huckel model for electrostatic potentials around dissolved DNA. Biophys J (1997) 0.98
Recent progress in potassium channel opener pharmacology. Biochem Pharmacol (1992) 0.97